Navigation Links
Neuraltus Pharmaceuticals Announces Phase 2 Clinical Results for NP001 in Patients with Amyotrophic Lateral Sclerosis (ALS)
Date:10/30/2012

lled 136 patients with ALS.  Patients were randomized to receive either placebo, or 1mg/kg or 2mg/kg intravenous infusion of NP001 over a period of six months, followed by a six-month follow-up period.  The study was designed to evaluate the change in slope of the ALS Functional Rating Score Revised (ALSFRS-R) and the safety and tolerability of NP001, as well as change from baseline in ALSFRS-R through six months, a joint rank analysis of change of ALSFRS-R adjusted for mortality and changes in readily measured peripheral inflammation biomarkers.  An additional secondary endpoint agreed upon with the FDA was the inclusion of matched historical placebo control ALS patients to increase signal detection and power.

Post hoc analysis of the Phase 2 study showed a dose response to NP001 with 27% of the patients who received 2mg/kg NP001 having no progression of their disease during the six-month dosing period.  This is approximately 2.5 times as many as were seen in the concurrent placebo group.  When historical placebo controls were included with concurrent controls, this difference versus placebo became statistically significant.  Although post hoc analysis must be considered cautiously and can be subject to bias, the magnitude of the benefit identified underscores a potentially clinically relevant and meaningful result.  In addition, results from the study demonstrated trends of clinical benefit for the 2 mg/kg cohort in the primary endpoint of change in slope of the ALSFRS-R, and in the secondary endpoints of change from baseline in ALSFRS-R through six months and a joint rank analysis of change of ALSFRS-R adjusted for mortality.

Neuraltus has established a toll-free number for patients and physicians to answer questions about the study.  That number, 1-888-347-7799, will be available through December 31, 2012.

About Neuraltus Pharmaceuticals, Inc.
Neuraltus Pharmaceuticals, Inc. is a priv
'/>"/>

SOURCE Neuraltus Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
2. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
3. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
4. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
5. Icahn Issues Statement Regarding Amylin Pharmaceuticals
6. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
7. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
8. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
9. Jazz Pharmaceuticals Announces First Quarter 2012 Financial Results Conference Call On May 8, 2012
10. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
11. Avanir Pharmaceuticals To Present at Three Conferences In May
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... 2015  AbbVie (NYSE: ABBV ) will participate ... 4, 2015. Richard A. Gonzalez , chairman and ... answer session at 8:30 a.m. Central time. ... accessible through AbbVie,s Investor Relations Web site at ... be available later that day. About ...
(Date:6/1/2015)... Research and Markets ( http://www.researchandmarkets.com/research/wjh6pr/global_power ) ... Power Wheelchair Industry Report 2014" report to ... Industry Report 2014 is a professional and in-depth ... wheelchair industry. The report provides a ... applications and industry chain structure. The power wheelchairmarket ...
(Date:6/1/2015)... BOSTON , June 1, 2015 Symbiotix ... a $2.3 million Phase 2 Small Business Technology Transfer ... (NIH) National Institute of Allergy and Infectious Diseases (NIAID). ... is developing a novel class of molecular therapeutics ... lead clinical candidate, Polysaccharide A (PSA), is the first ...
Breaking Medicine Technology:Global Power Wheelchair Industry Trends 2015-2020 2Symbiotix Biotherapies Announces $2.3 Million Award from NIH's National Institute of Allergy and Infectious Diseases (NIAID) 2
... Cantel Medical Corp. (NYSE: CMN ) will ... ended July 31, 2011 on Thursday, October 13 before the ... results at 11:00 AM ET.  Participating in the call will ... CEO; Seth R. Segel, Executive Vice President; and Craig A. ...
... Microflex Corporation (Lake Forest, IL), a ... of latex and synthetic barrier protection products, is excited ... the first glove to receive an ergonomic certification.   ... Ergonomics, the leader in ergonomic testing and certifications in ...
Cached Medicine Technology:Cantel Medical Corp. to Hold Conference Call to Discuss Fourth Quarter and Fiscal 2011 Results 2Microflex XCEED®--First Certified Ergonomic Disposable Examination Glove 2
(Date:6/1/2015)... Listen to Volvo’s Director of Connectivity ... using more granular data to create better customer oriented ... voices in Josep Celaya Gonzalez, CIO at MAPFRE, and ... an automotive insurer, MAPFRE are well versed in capturing ... to the driver. Award winning start-up ParkTAG offer an ...
(Date:6/1/2015)... Norcross, GA. (PRWEB) June 01, 2015 ... Producer Online, which is a new cloud-based subscription service ... sensing and GIS software. , Both ERDAS IMAGINE ... online access through Producer Online, which offers a subscription ... , “Today’s organizations need to be able to quickly ...
(Date:6/1/2015)... (PRWEB) June 01, 2015 The session, ... include Artur Seidel, vice president of Elektrobit Automotive ... consultant John Ellis; it will be moderated by Andy ... the growing importance and complexity of in-vehicle software in ... issues of security and how the wider ecosystem can ...
(Date:6/1/2015)... This is the final call for registration ... of Local Food, June 11 - 13 at The ... cities in examining and developing solutions to strengthen their ... for the city of Riverside by Seedstock co-founder Robert ... speakers ranging from urban agriculture entrepreneurs, USDA representatives from ...
(Date:6/1/2015)... If you dread visiting a dentist because of ... some encouraging news. With an idea created by two ... Marcos, Calif., you no longer need to worry. , ... to provide improved oral suction needed for dental exams, ... dental patient’s throat more comfortable by removing excess fluids ...
Breaking Medicine News(10 mins):Health News:Complimentary Webinar: Volvo, MAPFRE and Award Winning Start-Up discuss new Frontier of In-Car Services 2Health News:Hexagon Geospatial Launches Cloud-Based Producer Online Suite 2Health News:Hexagon Geospatial Launches Cloud-Based Producer Online Suite 3Health News:Elektrobit Automotive, Ford and Delphi to Tackle In-Vehicle Software at TU-Automotive Detroit 2015 2Health News:Elektrobit Automotive, Ford and Delphi to Tackle In-Vehicle Software at TU-Automotive Detroit 2015 3Health News:Limited Tickets Available for “GrowRIVERSIDE” Conference June 11 2Health News:All-in-One Dental Aspirator Invented by InventHelp® Clients (SDB-733) 2
... , 221.10.254.64 GALVESTON, Texas Hydrogen sulfide is a ... Sometimes called "swamp gas," this toxic substance is generally associated ... as odd as it may seem it also plays ... of diabetes, according to a new study from the University ...
... Reporter , TUESDAY, Aug. 2 (HealthDay News) -- Special bioengineered spinal ... least in rats, a new study shows. While trials in ... collagen, may one day help people with back pain caused by ... the more artificial replacement discs in use today. "These ...
... uses fruit flies to study the genetics of cancer has ... Marios Georgiou, lecturer in cell biology in the University,s School ... Establishment Award of 600,000. The award is given every year ... cancer scientists of the future. Cancer Research UK ...
... , MONDAY, Aug. 1 (HealthDay News) -- Four of ... for the diagnosis and treatment of chronic obstructive pulmonary ... the recommendations are based on more recent studies of ... are meant largely to emphasize how critical it is ...
... indicates cholesterol lowering drugs known as statins may help prevent ... stroke. The study is published in the August 2, 2011, ... the American Academy of Neurology. "Because the cause ... cholesterol-lowering drugs are often not used to prevent further strokes ...
... 1 (HealthDay News) -- Teens are much more likely to ... school in neighborhoods with many fast food restaurants and other ... compared 2007 data on junk food consumption by California teens ... such as fast food restaurants, convenience stores, dollar stores and ...
Cached Medicine News:Health News:Scientists show 'swamp gas' protects blood vessels from complications of diabetes 2Health News:Bio-Engineered Spinal Discs Appear Successful in Rats 2Health News:Bio-Engineered Spinal Discs Appear Successful in Rats 3Health News:Nottingham scientist wins major cancer research award 2Health News:Nottingham scientist wins major cancer research award 3Health News:New Guidelines for Spotting, Treating COPD Released 2Health News:Cholesterol-lowering drugs may help prevent recurrent strokes in younger people 2Health News:With Junk Food Stores Nearby, Teens May Eat More of It 2
... The Accommodating Intraocular Lens is for the treatment ... in many middle aged and older patients. , ... in the natural lens of the eye as ... less elastic. With less elasticity, the eye has ...
Designed with your input, the ATS Simulus™ flexible annuloplasty ring and band are easy endings to complex mitral valve repairs....
The Victory single- and dual-chamber rate-responsive pacemakers from St. Jude Medical are advanced-feature systems, designed to save valuable clinic time, maximize patient safety, and provide other t...
... right for the not-so-typical patient. , With ... ability to address the atypical situations that ... after implant. St. Jude Medical ICDs feature ... in almost any situation, from high defibrillation ...
Medicine Products: